ZyVersa Therapeutics ZVSA
OTC ZVSA
$0.00 -0.05 (-100.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

ZyVersa Therapeutics, Inc. (ZVSA) Income from Continuing Operations (2022 - 2026)

Updated

ZyVersa Therapeutics (ZVSA) reported Income from Continuing Operations of -$1.3 million for Q1 2026, compared with -$2.14 million a year earlier.

Analysis

ZyVersa Therapeutics, Inc. (ZVSA) Income from Continuing Operations (2022 - 2026) Analysis & Trends

Over the twelve months ended Mar 31, 2026, ZyVersa Therapeutics' Income from Continuing Operations came in at -$24 million; for FY2025, it came in at -$24.95 million.

  • By year, Income from Continuing Operations came in at -$9.41 million in FY2024, -$98.3 million in FY2023 and -$14.05 million in FY2022.
  • Five-year quarterly Income from Continuing Operations spans a low of -$78.51 million in Q2 2023 and a high of -$678,572 in Q4 2025.
  • Per Business Quant data, the three quarters before Q1 2026 came in at -$678,572 (Q4 2025), -$19.81 million (Q3 2025) and -$2.21 million (Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.30 Mn
Dec 31, 2025 -678,572.00
Sep 30, 2025 -19.81 Mn
Jun 30, 2025 -2.21 Mn
Mar 31, 2025 -2.14 Mn
Dec 31, 2024 -1.42 Mn
Sep 30, 2024 -2.40 Mn
Jun 30, 2024 -2.76 Mn
Mar 31, 2024 -2.83 Mn
Dec 31, 2023 -13.34 Mn
Sep 30, 2023 -2.90 Mn
Jun 30, 2023 -78.51 Mn
Mar 31, 2023 -3.54 Mn
Jun 30, 2022 -2.00 Mn
Mar 31, 2022 -801,048.00
API Access

ZyVersa Therapeutics, Inc. Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ZVSA&period=max&api_key=YOUR_API_KEY